Clinical Trial Update: Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating docetaxel versus paclitaxel for women with unresectable locally advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxol (paclitaxel)
• Taxotere (docetaxel)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN